CDK2AP2
CDK2AP2 (cyclin dependent kinase 2 associated protein 2, also known as DOC-1R or p14) is a member of the CDK2AP family. It is a component of the NuRD chromatin-remodelling complex and restrains the G1/S phase transition by repressing CDK2. Browse Assay Genie's current range of CDK2AP2 research reagents below, or read on for the biology behind the target.
CDK2AP2 acts as a component of the histone deacetylase NuRD complex, which participates in the remodelling of chromatin. It also inhibits the G1/S phase transition of the cell cycle by repressing CDK2 expression and activation. It limits CDK2 activation by inhibiting the interaction of CDK2 with cyclin E and cyclin A, which places the protein at a key control point between cell cycle progression and chromatin regulation.
Beyond the cell cycle, CDK2AP2 plays a role in regulating the self-renewal of embryonic stem cells (ESCs) and in maintaining cell survival during terminal differentiation of ESCs. It also regulates the microtubule organisation of metaphase II oocytes. UniProt records the protein in both the cytoplasm and the nucleus, and assigns it to the CDK2AP family.
The CDK2AP2 gene encodes a protein that interacts with cyclin-dependent kinase 2 associated protein 1. According to the RefSeq summary, pseudogenes associated with the gene are located on chromosomes 7 and 9, and alternatively spliced transcript variants have been observed. The protein is also known as DOC-1R and p14, and was previously named CDK2-associated protein 2. The mouse ortholog is Cdk2ap2. Researchers studying the CDK2AP2 protein, or using a CDK2AP2 antibody or CDK2AP2 ELISA kit, are typically interested in its links to CDK2 control, chromatin remodelling and stem cell biology.
CDK2AP2 inhibits the G1/S transition by repressing CDK2 expression and by blocking CDK2 interaction with cyclin E and cyclin A.
As a component of the histone deacetylase NuRD complex, CDK2AP2 participates in the remodelling of chromatin.
CDK2AP2 helps regulate ESC self-renewal and maintains cell survival during terminal differentiation of ESCs.
CDK2AP2 regulates the microtubule organisation of metaphase II oocytes, linking it to oocyte maturation research.
CDK2AP2 is a component of the NuRD histone deacetylase complex, involved in chromatin remodelling. It inhibits the G1/S transition by repressing CDK2 expression and activation, and by blocking CDK2 binding to cyclin E and cyclin A. It also affects ESC self-renewal and oocyte microtubule organisation.
CDK2AP2 is also called DOC-1R and p14, and its previous name was CDK2-associated protein 2. The RefSeq summary notes that alternatively spliced transcript variants have been observed for the gene. It belongs to the CDK2AP family, which also includes CDK2AP1, its reported interaction partner.
A mouse ortholog, Cdk2ap2, is recorded for the human gene. The human gene also has pseudogenes on chromosomes 7 and 9. For work in other species, check the datasheet of any product for its validated reactivity.
Cyclin-dependent kinases and CDK inhibitors that act alongside CDK2AP2 in cell cycle regulation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O75956; product specifications from Assay Genie datasheets.